Key result
Significant native valvular disease is not independently associated with adverse outcomes in AF.
Why the study?
The characteristics and prognostic implications of patients with AF classified as nonvalvular who have significant native VHD other than mitral stenosis have not been extensively studied.
Does the presence of significant valvular heart disease in patients with atrial fibrillation affect the risk of adverse cardiovascular outcomes?
Cohort (n=1,885)
No
Does the presence of significant valvular heart disease in patients with atrial fibrillation affect the risk of adverse cardiovascular outcomes?
Hazard Ratio: 1.28 (95% CI 0.94–1.74)
p-value: p=0.116
The structural and functional cardiac consequences of valvular heart disease are more important determinants of adverse outcomes in AF patients than the specific clinical classification of AF type.
Valvular classification may not add independent prognostic value in AF beyond echocardiography; hypothesis-generating for prioritizing structural parameters in risk models.
Valvular atrial fibrillation (AF) is defined as AF in the presence of mitral stenosis or mechanical valve prosthesis. However, there are patients with AF who have significant native valvular heart disease (VHD) others than mitral stenosis that are classified as nonvalvular AF. The characteristics and prognostic implications of these entities have not been extensively studied. Of 1,885 AF patients referred for electrical cardioversion (64 ± 13years, 71% male), 171 (9.1%) had valvular AF (any grade of mitral stenosis or mechanical/biological valve prostheses) and 1,714 patients were identified as nonvalvular AF, of whom 329 (17.5%) had significant left-sided VHD. Patients with nonvalvular AF but with significant left-sided VHD were older, more frequently women and had more co-morbidities compared with the other groups. Furthermore, nonvalvular AF patients with significant left-sided VHD showed the worst left ventricular systolic function and largest left atrial volumes. During a median follow-up of 64 months (interquartile range: 33 to 96 months), 488 patients presented with the combined endpoint of all-cause mortality, heart failure hospitalization, and ischemic stroke. Patients with nonvalvular AF and with significant left-sided VHD had more events of heart failure whereas patients with valvular AF had higher all-cause mortality events. There were no differences in ischemic stroke events. Type of AF was not associated with outcomes after correcting for echocardiographic variables. In conclusion, the frequency of AF patients with significant VHD is relatively high. The consequences of VHD and AF on cardiac structure and function are more important determinants of adverse outcome than the type of AF.
No takes yet. Share an insight, caveat, or question.
Vo et al. (2020) conducted a cohort in Atrial fibrillation with and without valvular heart disease (n=1,885). Significant left-sided valvular heart disease vs. Nonvalvular atrial fibrillation without significant valvular heart disease was evaluated on Combined endpoint of all-cause mortality, heart failure hospitalization, and ischemic stroke (HR 1.28, 95% CI 0.94-1.74, p=0.116). In patients with atrial fibrillation, the presence of significant native valvular heart disease was not independently associated with adverse outcomes after correcting for echocardiographic variables.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: